test

Craig Skaling

@Tcg Crossover Management, Llc

Latest period2024 - Q3ReportedManaged Assets$1.18BTotal holdings36
Assets growth rate23.02%Assets growth rate (2-Q avg)-0.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Tcg Crossover Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Tcg Crossover Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.18B in assets, with a quarterly growth rate of 23.02% and a 2-quarter average growth rate of -0.56%. The portfolio is managed by Craig Skaling, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CGONCg Oncology, Inc.
Recent Activity
11.74%
$138.477M
3.67M shares@ $37.73 avg price
DYNDyne Therapeutics, Inc
Recent Activity
8.07%
$95.193M
2.65M shares@ $35.92 avg price
COGTCogent Biosciences Inc
Recent Activity
6.38%
$75.215M
6.964M shares@ $10.8 avg price
ABVXAbivax Sa
Recent Activity
5.92%
$69.772M
6.057M shares@ $11.53 avg price
EWTXEdgewise Therapeutics, Inc.
Recent Activity
Decreased -7.02%
4.78%
$56.396M
2.113M shares@ $26.7 avg price
SLNSilence Therapeutics Plc
Recent Activity
Decreased -7.94%
4.68%
$55.15M
3.034M shares@ $18.19 avg price
SVRASavara Inc.
Recent Activity
4.45%
$52.416M
12.362M shares@ $4.24 avg price
KROSKeros Therapeutics, Inc.
Recent Activity
4.33%
$51.064M
879,344 shares@ $58.07 avg price
XNCRXencor Inc
Recent Activity
New Position
4.14%
$48.81M
2.427M shares@ $20.11 avg price
TYRATyra Biosciences Inc
Recent Activity
3.97%
$46.764M
1.989M shares@ $23.52 avg price